CLINICAL_TRIALS
trial_result
· 2014-12-04
Clinical Trial Update: Finasteride for Chronic Central Serous Chorioretinopathy [Phase 2]
Summary
A National Eye Institute-sponsored Phase 2 trial of finasteride for chronic central serous chorioretinopathy was terminated, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Eye Institute (NEI) | Conditions: Retinal Disease | Phase 2 | Status: TERMINATED | Results posted: 2014-12-04